1. Home
  2. OLN vs ARQT Comparison

OLN vs ARQT Comparison

Compare OLN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$25.04

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$24.57

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
ARQT
Founded
1892
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.9B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
OLN
ARQT
Price
$25.04
$24.57
Analyst Decision
Hold
Strong Buy
Analyst Count
13
6
Target Price
$25.23
$34.00
AVG Volume (30 Days)
1.8M
1.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
$6,780,800,000.00
$376,072,000.00
Revenue This Year
$2.57
$34.85
Revenue Next Year
$3.51
$29.39
P/E Ratio
N/A
N/A
Revenue Growth
3.68
91.34
52 Week Low
$18.08
$13.06
52 Week High
$30.46
$31.77

Technical Indicators

Market Signals
Indicator
OLN
ARQT
Relative Strength Index (RSI) 44.21 66.61
Support Level $22.82 $22.41
Resistance Level $26.84 $25.25
Average True Range (ATR) 0.85 0.94
MACD -0.09 0.48
Stochastic Oscillator 41.51 85.49

Price Performance

Historical Comparison
OLN
ARQT

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: